Marketing-authorisation holder · Italy
Acs Dobfar SPA
38 medicines in 3 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Italy
38 medicines in 3 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 38
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CEFTAZIDIME1gm/vial | 2gm/vial | 500mg/vial | 6gm/vial · Injectable | Ceftazidime | United States | Marketed | 1985 |
| ERTAPENEM ACS DOBFARPolvere per concentrato per soluzione per infusione | Ertapenem | Italy | Authorised | |
| KEFUROX1.5gm base/vial | 7.5gm base/vial · Injectable | Cefuroxime | United States | Not marketed | 1986 |
| KEFUROX750mg base/vial · Injectable | Cefuroxime | United States | Not marketed | 1986 |
| KEFZOL10gm base/vial | 1gm base/vial | 20gm base/vial | 250mg base/vial | 500mg base/vial · Injectable | Cefazolin | United States | Not marketed | 1973 |
| MEROPENEM1gm/vial | 500mg/vial · Injectable | Meropenem | United States | Marketed | 2010 |
| MEROPENEM ACS DOBFARPolvere per soluzione iniettabile/per infusione | Meropenem | Italy | Authorised | |
| CECLOR 125MG-5ML SUSP | Cefaclor | Saudi Arabia | Authorised | |
| CECLOR 250 MG-5ML SUSP | Cefaclor | Saudi Arabia | Authorised | |
| CECLOR 250MG CAPSULE | Cefaclor | Saudi Arabia | Authorised | |
| CECLOR 500MG CAPSULE | Cefaclor | Saudi Arabia | Authorised | |
| CECLOR MR 375 MG TAB | Cefaclor | Saudi Arabia | Authorised | |
| CECLOR MR 500MG TAB | Cefaclor | Saudi Arabia | Authorised | |
| CECLOR MR 750 MG TAB | Cefaclor | Saudi Arabia | Authorised | |
| Imesta 500 mg/500 mg Powder For IV Infusion (10S) | Cilastatin, Imipenem | Saudi Arabia | Authorised | |
| Imesta 500 mg/500 mg Powder For IV Infusion (1Vial) | Cilastatin, Imipenem | Saudi Arabia | Authorised | |
| Imipenem/Cilastatin Kabi 500MG/500MG VIAL | Cilastatin | Saudi Arabia | Authorised | |
| IMIPENEM-CILASTATIN LABATEC 500/500 VIAL | Cilastatin, Imipenem | Saudi Arabia | Authorised | |
| IVNEM | Cilastatin, Imipenem | Saudi Arabia | Authorised | |
| KEFLEX 250MG-5ML SUSPENTION | Cefalexin | Saudi Arabia | Authorised | |
| KEFLEX 500MG TAB | Cefalexin | Saudi Arabia | Authorised | |
| MERONEM 1GM VIAL I-V | Meropenem | Saudi Arabia | Authorised | |
| MERONEM 1GM VIAL I-V | Meropenem | Saudi Arabia | Authorised | |
| MERONEM 500MG VIAL I-V | Meropenem | Saudi Arabia | Authorised | |
| MERONEM 500MG VIAL I-V | Meropenem | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 31 | 31 | 0 | CompaniesAll medicines |
| United States | 5 | 5 | 0 | CompaniesAll medicines |
| Italy | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Croatia, France, Serbia, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Report an error or request removalCorrections from the company itself are welcome.
Licence: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci-con-dettaglio-autorizzazioni/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:44.771040+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Ranked by their number of medicines.